Clinical trial · Observational
Detection of Benign and Malignant Thyroid and Breast Tumors by Fourier Transform Infrared Spectrometry
NCT01668238CI-TRIAL-00007852unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this stage of study is to establish discriminant among healthy tissue, benign and malignant thyroid and breast tumors by fourier transform infrared spectrometry variables.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Tumor | Breast Neoplasm | ALIAS | 0.90 |
| Thyroid Tumor | Thyroid Gland Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (3)
- label
- malignant tumor
- description
- Inpatients with malignant tumors of thyroid and breast
- label
- benign tumor
- description
- Inpatients with benign tumors of thyroid and breast
- label
- Healthy volunteers
- description
- Volunteers without thyroid or breast tumors
Primary outcomes (1)
- measure
- pathologic findings
- timeFrame
- 12 months
- description
- 1. In operation patients, discriminant between benign and malignant thyroid and breast tumors are established by fourier transform infrared spectrometry variables, and pathologic diagnoses are gold standard. 2. Between Patients and healthy volunteers, discriminant are established among thyroid and breast tumors and healthy tissues.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Patients: 1. Inclusion Criteria: * Patients undergoing thyroid and breast tumor surgery. * Informed consent form is signed. * An optical fibre and ATR probe can be applied to the operation field in process of open or laparoscopic surgery. * Male or female between the age of 18 to 80. * Patients can tolerate surgery and with non of these diseases: severe heart failure, liver failure, renal failure or respiratory failure. 2. Exclusion Criteria: * A state of emergency, such as Gastrointestinal bleeding, perforation, or acute obstruction. * unstable situation in operation, such as anesthetic accidents or intraoperative cerebral vascular accident. * From investigators' perspective patients do not suitable for the study Healthy volunteers' inclusion criteria: * Informed consent form is signed. * No thyroid or breast cancer according to the professional judgment of general surgeon. * No thyroid or breast disease according to thyroid function tests and breast type B-ultrasonic test within 3 months.
References
Publications (0)
Data not yet available
No reference posted for this study.